Dnistrian A M, Skipski V P, Barclay M, Stock C C
J Natl Cancer Inst. 1979 Feb;62(2):367-70.
Neutral glycosphingolipids and gangliosides were quantified in lipid extracts from plasma membranes, mitochondria, microsomes, and nuclei isolated from normal rat liver and Morris hepatoma 5123TC. Results showed a higher content of glycosphingolipids, especially gangliosides, in hepatomas and differences in the distribution of glycosphingolipids among subcellular fractions. Differences in the glycosphingolipid composition of the hepatoma, namely, the absence of trisialogangliosides and an increase in the lower molecular weight gangliosides, reflected an altered metabolism of glycosphingolipids in this tumor. The results indicated that changes in membrane glycosphingolipids were not restricted to the cell surfaces of malignant cells, inasmuch as intracellular membrane fractions also exhibited altered glycosphingolipid profiles.
对从正常大鼠肝脏和莫里斯肝癌5123TC分离出的质膜、线粒体、微粒体和细胞核的脂质提取物中的中性糖鞘脂和神经节苷脂进行了定量分析。结果显示,肝癌中糖鞘脂尤其是神经节苷脂的含量较高,并且亚细胞组分间糖鞘脂的分布存在差异。肝癌中糖鞘脂组成的差异,即三唾液酸神经节苷脂的缺失和低分子量神经节苷脂的增加,反映了该肿瘤中糖鞘脂代谢的改变。结果表明,膜糖鞘脂的变化并不局限于恶性细胞的细胞表面,因为细胞内膜组分也表现出糖鞘脂谱的改变。